Overview
Study to evaluate the safety and performance of the Innovalve mitral valve replacement system
Description
The study is a multi-center, First-In-Human, prospective, single arm early feasibility study to evaluate the safety and performance of the Innovalve mitral valve replacement system
Eligibility
Inclusion Criteria:
- Clinically significant, symptomatic mitral regurgitation
- High risk for open-heart surgery
- Meets anatomical criteria
Exclusion Criteria:
- Unsuitable anatomy
- Patient is inoperable
- EF<25%